Dr. Bishoy Morris Faltas is an Associate Professor of Medicine and Attending in the Genitourinary Oncology Program in the Division of Hematology & Medical Oncology at Weill Cornell Medicine. Dr. Faltas is the Chief Research Officer of the Caryl and Israel Englander Institute for Precision Medicine focusing on the application of genomic approaches to clinical trials by tailoring treatment based on the unique molecular profile of each patient's cancer.

Dr. Faltas completed his Hematology and Medical Oncology Fellowship at Weill Cornell Medicine, as well as additional training through a research fellowship in the laboratory of Dr. Mark A. Rubin. During this time, he led studies of the clonal evolution and the neoantigenic structure of platinum-resistant bladder cancer. As a physician-scientist, Dr. Faltas's laboratory (https://faltaslab.weill.cornell.edu/) conducts research focusing on understanding the molecular profiles of metastatic platinum-resistant urothelial bladder cancer. His research focus is on the mechanisms of mutagenesis and drug resistance in bladder carcinoma, as well as immunogenomic studies of urological malignancies. By understanding the molecular changes that occur as urothelial cancer evolves under the effect of chemotherapy and metastatic spread, Dr. Faltas aims to identify potential drug targets for translation into therapeutic clinical trials.

Dr. Faltas is the recipient of several research awards, including the Scott-Wadler Fellow Research award and the Weill Department of Medicine Fellow Award in Research. He has also received the NIH/NCATS CTSC KL2 Scholar grant, the American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award, the American Society of Clinical Investigation Young Physician-Scientist Award, the American Association for Cancer Research (AACR) NextGen Star award, the Society for Basic Urologic Research (SBUR) Young Investigator Award, the Department of Defense Career Development Award, the Irma T. Hirschl and Monique Weill-Caulier Research Award, and the prestigious R37 MERIT award from the National Cancer Institute.

Dr. Faltas has published several articles in peer-reviewed journals such as Nature, Nature Genetics, and Nature Communications. Additionally, he is a reviewer for several journals including Nature and Nature Communications, and a member of several grant Review Committees. Dr. Faltas is a member of the editorial board of the ASCO Post. He also served as an Associate Scientific Advisor for the journal Science Translational Medicine.